Hyloris Pharmaceuticals SA
3.4 FTEHyloris Pharmaceuticals reported revenue of €3.82m for the 2025 financial year (non-consolidated annual accounts filed with the NBB on 07 Jul 2026), with 3.4 full-time equivalents.
The score of Hyloris Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +217 % Equity -18 % Total assets -14 % Headcount (avg FTE) +278 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hyloris Pharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €3.82m | ||||
| Net result | −€1.21m | ||||
| Equity | €87.2m | ||||
| Cash | €11.7m | ||||
| EBITDA | −€2.10m | ||||
| Total assets | €101.5m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 13 Nov 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Hyloris Pharmaceuticals's financial analysis
- Solvency85.8%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hyloris Pharmaceuticals
14 active director(s) in the register.
and 8 more
Hyloris Pharmaceuticals's shareholders and holdings →Hyloris Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0674.494.151
- VAT number
- BE0674494151
- Peppol
- Registered · 0208:0674494151 · as of 12 Nov 2026
- Legal form
- SA
- Incorporated
- 10 Apr 2017
- Registered office
- 4000 Liège
- Size
- Micro · 3.4 FTE
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Hyloris Pharmaceuticals (SA) has been based in Liège since 2017, active in: activities of holding companies. For 2025, it reports revenue of €3.82m, a net loss of €1.21m and equity of €87.2m. With 3.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 85.8%, above the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Hyloris Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Besins Healthcare Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €110.7m
- Finicoma Business and other management consultancy activities Ghent · balance sheet €83.6m
- Newpharma Group Activities of head offices Liège · balance sheet €109.2m
- Financiere Sud Sante Activities of holding companies Etterbeek · balance sheet €101.9m
- Healis Holding Activities of holding companies Geel · balance sheet €53.0m
- Medigroup Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €30.2m
- MedCare Partners Activities of holding companies Bornem · balance sheet €81.7m
- Bobbie Pharmaceutical Services Activities of holding companies Wingene · balance sheet €47.0m
Frequently asked questions about Hyloris Pharmaceuticals
What is the revenue of Hyloris Pharmaceuticals?
According to the 2025 annual accounts filed with the NBB, the revenue of Hyloris Pharmaceuticals amounts to 3,817,735 €.
What is the VAT number of Hyloris Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0674494151 for Hyloris Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0674.494.151.
Where is the registered office of Hyloris Pharmaceuticals?
According to the CBE register, the registered office of Hyloris Pharmaceuticals is in 4000 Liège.
What is the equity of Hyloris Pharmaceuticals?
At the close of the 2025 financial year, the equity of Hyloris Pharmaceuticals amounts to 87,154,867 €, a solvency of 85.8% of total assets.
How many people work at Hyloris Pharmaceuticals?
3.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Hyloris Pharmaceuticals?
The register lists 14 active mandates at Hyloris Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hyloris Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →